Published in Health and Medicine Week, October 20th, 2003
The new material will help researchers seeking the genetic basis for a wide range of diseases, including glaucoma, advanced macular degeneration, and diabetic retinopathy. The bank includes materials from systemic diseases affecting the eye such as vascular disease and hypertension.
Announcing the availability of the material this week, Asterand CEO Randal Charlton said, "Many of the world's major biotechnology companies are targeting ocular diseases. Many of these companies give...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.